February 10, 2025

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Join the ACR® for an informative webinar on February 19 from 5-6pm ET covering how to distinguish immune-related vs. radiation pneumonitis following thoracic radiotherapy.

Read more under "News"

Register here today

CLOSURES & SUSPENSIONS

BREAST

EAY191-N2/ComboMATCH: Notice of Closure to Accrual, dated February 7, 2025 (posted on CTSU)

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BIOSPECIMEN BANKS

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

3. BREAST

NRG-BR009/OFSET: Memorandum, dated February 10, 2025, regarding availability of Spanish versions of patient-directed materials (posted on CTSU)

4. CANCER PREVENTION & CONTROL

NRG-CC005/FORTE: FORTE Fridays newsletter

NRG-CC010: The study is open to NRG sites in Japan and South Korea. The optional biospecimen collection does not apply to sites participating in these countries.

5. GYNECOLOGIC

NRG-GY026: Please note, the post-chemo cfDNA Whole Blood (WB03) should only be collected if the Pre-Treatment cfDNA Whole Blood (WB01) was collected.

NRG-GY031: Please note, there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

6. HEAD & NECK

NRG-HN008

Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important.

7. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, NRG-BR009, NRG-BN014, NRG-CC011, NRG-CC013, NRG-HN014 and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for February 12, 2025.

Drug Safety updates have been issued for the following studies:

1. Winter Meeting Slides

Check the NRG Oncology Meeting Webpages in the coming days for session presentation slide postings as they become available.

2. REGISTER TODAY: Distinguishing Immune-Related vs. Radiation Pneumonitis Following Thoracic Radiotherapy Webinar

Join the ACR® for an informative webinar on February 19^th from 5:00-6:00pm ET covering how to distinguish immune-related vs. radiation pneumonitis following thoracic radiotherapy (RT).

National experts in radiology will discuss interpreting findings seen on post-treatment CT and PET imaging after RT for thoracic malignancies; understanding the pathophysiology, clinical features, and diagnostic strategies to differentiate between radiation-related and immune-related pneumonitis; and understanding the management of radiation and immune-related pneumonitis. This webinar is relevant to all radiation and medical oncologists.  

Hosts: Rituraj Upadhyay, MD, Emile Gogineni, DO, and Arya Amini, MD

Speakers: Drew Moghanaki, MD and Sharyn Katz, MD

Register here today

3. Translational Science Committee Soliciting Pilot Projects for Inclusion in the NRG UG1 Translational Science Center Application

The NRG Oncology Translational Science Committee is soliciting one-page proposals (with Specific Aims) for pilot projects to incorporate into their “Network Group Integrated Translational Science Center” application due in February 2025. More information available here.

4. NRG Oncology Seeking Candidate for Deputy NCORP PI Role

We are seeking nominations for the position of Deputy NCORP PI. The NCI Community Oncology Research Program (NCORP) brings cancer research studies and results to patients in a variety of community settings across the United States. NRG is one of seven NCORP research bases and one of only four focused on adults with cancer. The focus of the NRG NCORP is on cancer control, cancer prevention and cancer care delivery. Patient reported outcomes and health disparities are cross-cutting themes incorporated into most NCORP protocols as well as NRG treatment trials. The deadline for the application submission is February 14, 2025. Read more

5. NRG Oncology Seeking Candidate for Cancer Control Committee Chair Role

We are seeking nominations for the position of Chair of the NRG NCORP Cancer Control Committee. Candidates for this position should have an active program of funded research and publications focused on the NRG cancer control priorities of improvement or delay in decline of neurocognitive function, reducing gender specific symptoms such as lymphedema and sexual function, and testing therapeutic delivery modifications to improve QoL and cost-effectiveness in localized cancers while maintaining efficacy. Candidates should have a track record of mentorship and a willingness to provide timely consultation to members and liaisons of NRG committees as concepts and protocols are being developed. In addition to leading the NRG Cancer Control Committee, this candidate will also serve as a co-chair of the Cancer Prevention and Control (CPC) Committee. This individual will work closely with the CPC on the priorities of the overall committee. The deadline for the application submission is February 14, 2025. Read more

6. NRG Oncology Seeking Sarcoma Working Group Chair & Vice Chair

NRG Oncology seeks two dynamic individuals who will bring outstanding leadership skills, a collaborative team science spirit, and sarcoma expertise to a vibrant and highly motivated national Cooperative Group network by joining us as Sarcoma Subcommittee Chair and Vice Chair. 

We are looking for candidates with nationally recognized expertise in sarcoma. Candidates must be at an NRG Oncology Member Institution and eligible to receive federal funding. Nominal funds from federal grants to offset related effort and travel to NRG Oncology meetings is provided. Additionally, candidates are required to have either completed the demographic information or have formally elected to opt-out as per the NRG Oncology Demographic Data Initiative. The deadline for the application submission is February 14, 2025. Read more

7. President’s Day Holiday Closures

The NRG Oncology Philadelphia East Operations Center, Buffalo SDMC, and San Francisco Biospecimen Bank locations will be closed for the President's Day holiday on Monday, February 17, 2025. All other NRG Oncology offices and bank locations will be open during regular business hours.

8. NRG Member Demographics Data Collection Initiative

We are excited to introduce the NRG Member Demographics Data Collection Initiative that will allow us to create a comprehensive member database, enabling us to better understand and serve our members. Your information will be kept secure and confidential, ensuring that your privacy is always protected. All members are encouraged to complete the form or indicate that they wish to opt out of this data collection initiative. 

Scan the QR code below or click this link to access the form. 

Questions? Read more here

NRG Oncology is pleased to report the scientific articles that appeared during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

PUBLISHED ARTICLES

Clements A, Enserro D, Strickland KC, Previs R, Matei D, Mutch D, Powell M, Klopp A, Miller DS, Small W Jr, DiSilvestro P, Spirtos N, Cosgrove C, Sfakianos G, Liu JR, Vargas R, Shahin M, Corr B, Dessources K, Ueland F, Warshal D, Gillen J, Secord AA. Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258. Gynecol Oncol. 2025 Jan 23;193:119-129. doi: 10.1016/j.ygyno.2025.01.006. Epub ahead of print. PMID: 39854806. Read more.

Flannery BT, Sandler HM, Lal P, Feldman MD, Santa-Rosario JC, Pathak T, Mirtti T, Farre X, Correa R, Chafe S, Shah A, Efstathiou JA, Hoffman K, Hallman MA, Straza M, Jordan R, Pugh SL, Feng F, Madabhushi A. Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens. J Pathol. 2025 Feb;265(2):146-157. doi: 10.1002/path.6373. Epub 2024 Dec 11. PMID: 39660731; PMCID: PMC11717490. Read more.

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS

American Association for Cancer Research (AACR); Apr 25-30, 2025; Chicago, IL

American Association for Thoracic Surgery (AATS); May 2-5, 2025; Seattle, WA

American Brachytherapy Society (ABS); Jun 18-21, 2025; Nashville, TN

American College of Radiology (ACR); May 3-7, 2025; Washington, DC

American Head & Neck Society (AHNS); May 14-15, 2025; New Orleans, LA

American Radium Society (ARS) Annual Meeting; Apr 3-6, 2025; Seattle, WA

American Surgical Association (ASA); Apr 24-26, 2025; San Diego, CA

American Society of Breast Surgeons (ASBrS); Apr 30-May 4, 2025; Las Vegas, NV

American Society of Clinical Oncology (ASCO) GU; Feb 13-15, 2025; San Francisco, CA

American Society of Colon and Rectal Surgeons (ASCRS); May 11-14, 2025; San Diego, CA

European Society of Gynaecological Oncology (ESGO); Feb 20-23, 2025; Rome, Italy

Miami Breast Cancer Conference; Mar 6-9, 2025; Miami, FL

Society for Clinical Trials (SCT); May 18-21, 2025; Vancouver, BC

Society for Gynecologic Oncology (SGO); Mar 14-17, 2025; Seattle, WA

Society of Surgical Oncology (SSO) Annual Meeting; Mar 27-29, 2025; Tampa, FL

SSO – Advanced Cancer Therapies; Feb 14-17, 2025; Scottsdale, AZ

St. Gallen Breast Cancer Conference; Mar 12-15, 2025; Vienna Austria

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Society of Clinical Oncology (ASCO); May 30-Jun 3, 2025; Chicago, IL; LBA Mar 5, 2025 (placeholder required)

American Society for Radiation Oncology (ASTRO); Sep 28-Oct 1, 2025; San Francisco, CA; Due to publications committee Feb 11, 2025; Submission deadline Feb 25, 2025, 11:59 pm PT; LBA Jul 10, 2025, 11:59 pm PT

Canadian Association of Radiation Oncology (CARO); Sep 10-13, 2025; Calgary, AB; Submission deadline Feb 20, 2025

European Society for Medical Oncology (ESMO); Oct 17-21, 2025; Berlin, Germany; Due to publications committee Apr 25, 2025; Submission deadline May 13, 2025, 21:00 CET; LBA Sep 9, 2025, 21:00 CET (placeholder required)

ESMO Breast Cancer; May 14-16, 2025; Munich, Germany; Submission deadline Feb 11, 2025, 21:00 CET; LBA Apr 15, 2025, 21:00 CET (placeholder required)

ESMO Gastrointestinal Cancers; Jul 2-5, 2025; Barcelona, Spain; Due to publications committee Mar 25, 2025; Submission deadline Apr 8, 2025, 21:00 CET; LBA Jun 5, 2025, 21:00 CET (placeholder required)

ESMO Gynaecological Cancers; Jun 19-21, 2025; Vienna, Austria; Due to publications committee Mar 18, 2025; Submission deadline Apr 1, 2025, 21:00 CET

European Society for Radiotherapy and Oncology (ESTRO); May 2-6, 2025; Vienna, Austria; LBA Mar 19, 2025

International Society for Quality-of-Life Research (ISOQOL); Oct 22-25, 2025; Milwaukee, WI; Due to publications committee Mar 25, 2025; Submission deadline Apr 7, 2025



Radiological Society of North America (RSNA); Nov 30-Dec 4, 2025; Chicago, IL; Due to publications committee Apr 23, 2025; Submission deadline May 7, 2025, Noon CT